Nevertheless, utilization of adiponectin may prove to be influential in the treatment of obesity-related nonalcoholic steatohepatitis (NASH), a condition underpinned by inflammation and accumulation of fat and fibrous tissue in the liver [25]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.